Abstract
Cancer is the leading cause of death worldwide. Despite all the advancements in cancer research, the year 2020 witnessed about 10 million deaths by Cancer. The conventional treatment modalities are often accompanied by unwanted side effects because of their non-specific nature. Nanotechnology has contributed to all sectors of science including medical science. Nanotherapy allows the manipulation, regulation and control of physicochemical properties of nanoparticles thus facilitating early diagnosis, targeted drug delivery and improved efficiency of conventional therapies. This review article gives an overview of clinical applications of nanomedicines for cancer, their mechanism of action and prime challenges faced during the formulation and internationalization of these nanosystems.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
